Details for Patent: 11,944,595
✉ Email this page to a colleague
Which drugs does patent 11,944,595 protect, and when does it expire?
Patent 11,944,595 protects LODOCO and is included in one NDA.
This patent has forty patent family members in twenty-four countries.
Drugs Protected by US Patent 11,944,595
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD FOR REDUCING A COMPOSITE ENDPOINT RISK OF MYOCARDIAL INFARCTION (MI), STROKE, CORONARY REVASCULARIZATION, UNSTABLE ANGINA REQUIRING HOSPITALIZATION, CARDIAC ARREST, AND CARDIOVASCULAR DEATH | ⤷ Sign Up | ||||
| Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD FOR REDUCING ACUTE MYOCARDIAL INFARCTION RISK | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,944,595
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013337605 | ⤷ Sign Up | |||
| Australia | 2018203715 | ⤷ Sign Up | |||
| Australia | 2019232879 | ⤷ Sign Up | |||
| Australia | 2021282491 | ⤷ Sign Up | |||
| Brazil | 112015010063 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
